These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36420759)

  • 1. Fenebrutinib and BTK inhibition: Unveiling a new target for the treatment of chronic spontaneous urticaria.
    Carvallo A; Sánchez-Fernández S; Morales-Palacios MP
    Allergy; 2023 Feb; 78(2):603-605. PubMed ID: 36420759
    [No Abstract]   [Full Text] [Related]  

  • 2. Fenebrutinib in H
    Metz M; Sussman G; Gagnon R; Staubach P; Tanus T; Yang WH; Lim JJ; Clarke HJ; Galanter J; Chinn LW; Chu T; Teterina A; Burgess T; Haddon DJ; Lu TT; Maurer M
    Nat Med; 2021 Nov; 27(11):1961-1969. PubMed ID: 34750553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.
    Skander D; Allenova A; Maurer M; Kolkhir P
    Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):91-93. PubMed ID: 32496030
    [No Abstract]   [Full Text] [Related]  

  • 4. Does synthetic pharmacotherapy still have a place in treating chronic spontaneous urticaria?
    Thiede RM; Fazel M; MacDonald KM; Abraham I
    Expert Opin Pharmacother; 2022 Oct; 23(14):1563-1567. PubMed ID: 36173375
    [No Abstract]   [Full Text] [Related]  

  • 5. Does hydroxychloroquine work for chronic spontaneous urticaria?
    Kaplan AP
    J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1983. PubMed ID: 37295866
    [No Abstract]   [Full Text] [Related]  

  • 6. Battling BTK mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations in Waldenström macroglobulinemia therapy: structural mechanistic insights on the role of fenebrutinib.
    Elamin G; Aljoundi A; Alahmdi MI; Abo-Dya NE; Soliman MES
    J Mol Model; 2022 Oct; 28(11):355. PubMed ID: 36222928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging treatments for chronic urticaria.
    Wedi B
    Expert Opin Investig Drugs; 2022 Mar; 31(3):281-290. PubMed ID: 35166638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective IgE Deficiency Predicts Poor or No Response of Chronic Spontaneous Urticaria to Omalizumab.
    Picado C; Mascaró JJ; Vlagea A; Pascal M; Muñoz-Cano R; Bartra J
    J Investig Allergol Clin Immunol; 2022 Dec; 32(6):504-506. PubMed ID: 35225792
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of the immunoglobulin/histamine complex in chronic spontaneous urticaria focusing on remission induction.
    Kim HS; Noh G
    Allergy; 2022 Sep; 77(9):2846-2848. PubMed ID: 35587440
    [No Abstract]   [Full Text] [Related]  

  • 10. Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study.
    Ghazanfar MN; Bartko EA; Arildsen NS; Poulsen LK; Jensen BM; Enevold C; Holm JG; Woetmann A; Ødum N; Thomsen SF
    Clin Exp Allergy; 2022 May; 52(5):715-718. PubMed ID: 35278253
    [No Abstract]   [Full Text] [Related]  

  • 11. Unique basophil microRNA signature in chronic spontaneous urticaria patients who respond to omalizumab.
    Al-Shaikhly T; MacDonald JW; Bammler TK; Altman MC; Ayars AG; Petroni DH; Tilles SA; Henderson WR
    Clin Exp Allergy; 2021 Dec; 51(12):1648-1652. PubMed ID: 34519110
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune chronic spontaneous urticaria.
    Kolkhir P; Muñoz M; Asero R; Ferrer M; Kocatürk E; Metz M; Xiang YK; Maurer M
    J Allergy Clin Immunol; 2022 Jun; 149(6):1819-1831. PubMed ID: 35667749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply to "Does hydroxychloroquine work for chronic spontaneous urticaria?".
    Bernstein DI; Khan N; Epstein TG
    J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1983-1984. PubMed ID: 37295865
    [No Abstract]   [Full Text] [Related]  

  • 14. Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis.
    Holm JG; Sørensen JA; Thomsen SF
    Int J Dermatol; 2022 May; 61(5):e173-e174. PubMed ID: 34813086
    [No Abstract]   [Full Text] [Related]  

  • 15. Definition of Recurrent Chronic Spontaneous Urticaria.
    Melé-Ninot G; Serra-Baldrich E; Curto-Barredo L; Figueras-Nart I; Spertino J; Expósito-Serrano V; García-Navarro X; Guilabert A; Bielsa-Marsol I; Giménez-Arnau AM
    Acta Derm Venereol; 2020 Sep; 100(16):adv00267. PubMed ID: 32926176
    [No Abstract]   [Full Text] [Related]  

  • 16. Biologics for chronic spontaneous urticaria: toward a personalized treatment.
    Asero R; Ferrucci S; Tedeschi A; Cugno M
    Expert Rev Clin Immunol; 2022 Dec; 18(12):1297-1305. PubMed ID: 36264653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the colchicine add-on therapy in patients with autoimmune chronic urticaria.
    Nabavizadeh SH; Babaeian M; Esmaeilzadeh H; Mortazavifar N; Alyasin S
    Dermatol Ther; 2021 Nov; 34(6):e15119. PubMed ID: 34469631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances.
    Kaplan A; Lebwohl M; Giménez-Arnau AM; Hide M; Armstrong AW; Maurer M
    Allergy; 2023 Feb; 78(2):389-401. PubMed ID: 36448493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and Future Approaches in Management of Chronic Spontaneous Urticaria Using Anti-IgE Antibodies.
    Orzan OA; Popa LG; Mihai MM; Cojocaru A; Giurcăneanu C; Dorobanțu AM
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort Study.
    Abduelmula A; Georgakopoulos JR; Mufti A; Devani AR; Gooderham MJ; Hong CH; Jain V; Lansang P; Vender R; Prajapati VH; Yeung J
    J Cutan Med Surg; 2022; 26(3):319-320. PubMed ID: 34587789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.